Raymond James & Associates’s SunOpta STKL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$65.3K Sell
10,228
-85
-0.8% -$498 ﹤0.01% 3826
2024
Q2
$55.7K Buy
+10,313
New +$60.6K ﹤0.01% 3785
2022
Q4
Sell
-10,144
Closed -$92K 4060
2022
Q3
$92K Buy
+10,144
New +$96.2K ﹤0.01% 3626
2021
Q4
Sell
-12,741
Closed -$114K 4279
2021
Q3
$114K Buy
12,741
+2,299
+22% +$23.2K ﹤0.01% 3810
2021
Q2
$128K Sell
10,442
-37,926
-78% -$495K ﹤0.01% 3793
2021
Q1
$714K Buy
48,368
+27,430
+131% +$393K ﹤0.01% 2744
2020
Q4
$244K Buy
+20,938
New +$184K ﹤0.01% 3257
2018
Q3
Sell
-100,986
Closed -$848K 3713
2018
Q2
$848K Sell
100,986
-14,236
-12% -$108K ﹤0.01% 2329
2018
Q1
$818K Sell
115,222
-1,609
-1% -$12K ﹤0.01% 2270
2017
Q4
$905K Sell
116,831
-981
-0.8% -$8.18K ﹤0.01% 2181
2017
Q3
$1.02M Sell
117,812
-2,957
-2% -$26.9K ﹤0.01% 2080
2017
Q2
$1.23M Buy
120,769
+38
+0% +$318 ﹤0.01% 1882
2017
Q1
$839K Buy
+120,731
New +$866K ﹤0.01% 2084

Other funds holding STKL

Raymond James & Associates's STKL Position: Q3 2024 in Review

Raymond James & Associates reduced its SunOpta (STKL) stake by 0.82% in Q3 2024, selling an estimated $498 and leaving 10,228 shares worth $65.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3826.

Raymond James & Associates first reported a position in STKL in Q1 2017 and has held it in 13 quarters since. The position peaked at $1.23M in Q2 2017. 194 funds tracked by Wall St. Rank hold STKL as of Q3 2024.

  • Raymond James & Associates held 10,228 shares of SunOpta worth $65.3K as of Q3 2024.
  • Raymond James & Associates sold 85 SunOpta shares in Q3 2024, an estimated $498.
  • SunOpta made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3826 holding.
  • Raymond James & Associates first reported a position in SunOpta in Q1 2017 and has held it in 13 quarters since.
  • Raymond James & Associates's SunOpta position peaked at $1.23M in Q2 2017.
  • 194 funds tracked by Wall St. Rank held SunOpta as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.